Enveric Biosciences Inc./$ENVB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
Ticker
$ENVB
Sector
Primary listing
Employees
6
Headquarters
Website
ENVB Metrics
BasicAdvanced
$4.8m
-
-$17.16
1.23
-
Price and volume
Market cap
$4.8m
Beta
1.23
52-week high
$13.25
52-week low
$1.29
Average daily volume
245k
Financial strength
Current ratio
11.668
Quick ratio
10.656
Interest coverage (TTM)
-20,000.21%
Profitability
EBITDA (TTM)
-8.063
Management effectiveness
Return on assets (TTM)
-96.72%
Return on equity (TTM)
-183.12%
Valuation
Price to book
0.48
Price to tangible book (TTM)
0.48
Price to free cash flow (TTM)
-0.11
Free cash flow yield (TTM)
-912.66%
Free cash flow per share (TTM)
-11.864
Growth
Earnings per share change (TTM)
-86.39%
ENVB News
AllArticlesVideos
Enveric Biosciences Announces Participation in 2026 BIO International Convention
Business Wire·2 days ago
Enveric Biosciences Reports Positive Preclinical Results from Phototoxicity Analysis for Lead Neuroplastogen Candidate EB-003
Business Wire·4 weeks ago
What's Going On With Enveric Biosciences Stock On Friday?
Benzinga·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs